ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
84 237,50
0,33%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Centessa Pharmaceuticals PLC (CNTA) Cours

Centessa Pharmaceuticals PLC

Centessa Pharmaceuticals PLC (CNTA)

NASDAQ
17,14
0,27
(1,60%)
Fermé 15 Mars 9:00PM
Retardé de 15 minutes
17,14
0,00
(0,00%)
Après les heures de négociation: 11:39PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
17,14
Prix Achat
12,69
Prix Vente
19,86
Volume échangé
1 372 754
16,27 Fourchette du Jour 17,50
0,00 Plage de 52 semaines 0,00
Cap du marché
2,26B
Clôture Veille
16,87
Ouverture
16,50
Dernière Transaction
400
@
17.14
(priorref)
Dernière heure de transaction
Volume financier
US$ 23 397 306
VWAP
17,0441
Volume moyen (3 m)
-
Actions en circulation
131 845 476
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
6,85M
Bénéfice net
-151,09M

À propos de Centessa Pharmaceuticals PLC

Centessa Pharmaceuticals PLC is a pharmaceutical company. Its portfolio consists of preclinical to phase 3 uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Some of its products include Vasopressin V2 ... Centessa Pharmaceuticals PLC is a pharmaceutical company. Its portfolio consists of preclinical to phase 3 uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Some of its products include Vasopressin V2 Receptor Inhibitor (Lixivaptan), BMP9 Engineered Variant (MGX292), OX2R Agonist (Oral) among others. Show more

Secteur
Coml Physical, Biologcl Resh
Industrie
Coml Physical, Biologcl Resh
Site Web
www.centessa.com
Siège social
Cheshire, Gbr
Fondé
-
Centessa Pharmaceuticals PLC est coté dans le secteur Coml Physical, Biologcl Resh de la NASDAQ avec le ticker CNTA. Le dernier cours de clôture d'Centessa Pharmaceuticals était de US$16,87. Au cours de la dernière année, les actions de Centessa Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Centessa Pharmaceuticals compte actuellement 131 845 476 actions en circulation. La capitalisation boursière d'Centessa Pharmaceuticals est de US$2,22 milliard.

CNTA Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
21 Février 2025
CNTA (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 Février 2025
CNTA (1,60%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
20 Février 2025
CNTA (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Février 2025
CNTA (1,60%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
18 Février 2025
CNTA (1,60%)

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Edgar (US Regulatory)
14 Février 2025
CNTA (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Février 2025
CNTA (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Février 2025
CNTA (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Février 2025
CNTA (1,60%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

CNTA - Frequently Asked Questions (FAQ)

What is the current Centessa Pharmaceuticals share price?
The current share price of Centessa Pharmaceuticals is US$ 17,14
How many Centessa Pharmaceuticals shares are in issue?
Centessa Pharmaceuticals has 131 845 476 shares in issue
What is the market cap of Centessa Pharmaceuticals?
The market capitalisation of Centessa Pharmaceuticals is USD 2,22B
What is the 1 year trading range for Centessa Pharmaceuticals share price?
Centessa Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Centessa Pharmaceuticals?
Centessa Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Centessa Pharmaceuticals?
The latest annual turnover of Centessa Pharmaceuticals is USD 6,85M
What is the latest annual profit for Centessa Pharmaceuticals?
The latest annual profit of Centessa Pharmaceuticals is USD -151,09M
What is the registered address of Centessa Pharmaceuticals?
The registered address for Centessa Pharmaceuticals is 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT
What is the Centessa Pharmaceuticals website address?
The website address for Centessa Pharmaceuticals is www.centessa.com
Which industry sector does Centessa Pharmaceuticals operate in?
Centessa Pharmaceuticals operates in the COML PHYSICAL, BIOLOGCL RESH sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CNTA
Centessa Pharmaceuticals
NASDAQ
PENG
Pengiun Solutions
LSE
87LV
Net.r.i. 1.375%
LSE
71OP
Lloyds Bk. 24
LSE
0MUF
Cenit
USOTC
KFCKF
Kentucky Fried Chicken (PK)
TG
2U3
Alcon
AMEX
DVW
Covad
TG
JE9N
Arianne Phosphate
COIN
GHOULUSD
GHOUL
COIN
FOURRUSD
Four
AMEX
TEMP
Jpmorgan Climate Change ...
CSE
NHS
NHS Industries
NYSE
MAS
Masco
NYSE
OWL
Blue Owl Capital
BOV
VAMO3
Vamos ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces